Publication | Closed Access

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

Translational MedicineSelective Phosphodiesterase-4 InhibitorMedicinePulmonary PharmacologyPharmacotherapyDose-ranging StudyPharmacologyPulmonary Disease